Data processing: financial – business practice – management – or co – Automated electrical financial or business practice or...
Reexamination Certificate
1999-10-22
2003-10-28
Weiss, John G. (Department: 3629)
Data processing: financial, business practice, management, or co
Automated electrical financial or business practice or...
Reexamination Certificate
active
06640211
ABSTRACT:
BACKGROUND OF THE INVENTION
This invention relates to a system for profiling and banking genetic information about individuals.
Genetic information derived from a sample can be used to determine medical and other information about an individual. Obtaining genetic samples and testing those samples raises concerns about privacy, access, and the use of the resulting information. Such information could, however, be useful for individuals and medical practitioners.
Currently there are companies that provide banking services for storing physical samples of genetic material from biological tissue, such as blood or cheek cells. That material can be retrieved from storage and tested as desired. Removing the sample and having it tested is time consuming and may be repetitive if multiple tests are needed over time.
SUMMARY OF THE INVENTION
The present invention includes systems and methods for storing and accessing genetic information. The systems and methods preferably provide protection against unauthorized access and use, but provide convenience in accessing and using genetic information if such use is properly authorized.
In a method according to the present invention, a patient enrolls in a genetic banking system and provides a source of genetic material, such as a blood sample. The sample is processed using a combination of experimental and/or in silico techniques to produce a genetic profile for the patients. The processed data is stored in a database to create a genetic profile for that patient. A remaining portion of the physical sample may also be stored for further use if needed.
The patient, either at the time of enrollment or after a sample is processed, can dictate access rights, including the ability of third parties (other than the individual or the genetic bank itself), such as medical practitioners, to access this profile, and the specific purposes for which the profile can be accessed and used. Thus, the patient can specify both the people who will have access, and the uses for which they have access.
The system provides user interfaces for the user to enter identification information and access rights. The bank can prepare standard protocols that describe allowed and proscribed data sharing.
A medical practitioner authorized to have access by the patient and confirmed by the access control system can access the profile that is stored and can run tests based on the profile as stored in the database; for example, such a test can be run to determine the presence or absence of certain markers.
In another aspect, a system according to the present invention includes a database for storing genetic data on individuals and an access control system that controls access to the database and manages the tests that are to be done. The control system interacts with (or includes) a testing system to cause the testing system to process the profile data to conduct the desired test. The control system authorizes the test and provides the results.
The system allows users to store a comprehensive digitized DNA profile based on a sample, in addition to storage of physical samples. The patient has control to voluntarily allow access to particular people and for particular purposes, thus protecting the privacy of that information. Because the samples have been processed and digitized, additional tests can be performed without requiring repetitive use of actual physical samples. Other features and advantages will become apparent from the following description of preferred embodiments, drawings, and claims.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 5050613 (1991-09-01), Newman et al.
patent: 5523208 (1996-06-01), Kohler et al.
patent: 5834181 (1998-11-01), Shuber
patent: 5876926 (1999-03-01), Beecham
patent: 5897989 (1999-04-01), Beecham
patent: 5920871 (1999-07-01), Macri et al.
patent: 5924074 (1999-07-01), Evans
patent: 5941947 (1999-08-01), Brown et al.
patent: 5993387 (1999-11-01), Moore et al.
patent: 6073106 (2000-06-01), Rozen et al.
patent: 6253203 (2001-06-01), O'Flaherty et al.
patent: 0913758 (1999-05-01), None
patent: 10239300 (1998-09-01), None
patent: 97/31327 (1997-08-01), None
patent: WO 9850154 (1998-11-01), None
Pulst, S.M., 1999 Neurol., vol. 56, No. 6, “Genetic Linkage Analysis”, pp. 667-672.*
Pulst, S.M., 1999 Neurol., vol. 56, No. 6, “Genetic Linkage Analysis”, pp. 667-672.
Ballantyne, et al., 1997 J. Cardiovasc. Risk, vol. 4, No.5-6, “Molecular Markers for Atherosclerosis”, pp. 353-356.
Marian, A.J. 1997 J. Cardiovasc. Risk, vol. 4, No. 5-6, “Genetic Markers: Genes Involved in Human Hypertension”, pp. 341-345.
Marian, A.J. 1997 J. Cardiovasc. Risk, vol. 4, No. 5-6, “Genetic Markers: Genes Involved in Atherosclerosis”, pp. 333-339.
Hallman, D.M.,et al., 1997 J. Cardiovasc. Risk, vol. 4, No. 5-6, “Molecular and Genetic Approaches to the Study of Cardiovascular Disease”, pp. 325-331.
Ballantyne, et al., 1997 J. Cardiovasc. Risk, vol. 4, No.5-6, “Genetic and Molecular Markers for Vascular Disease”, pp. 321-323.
Zehbe, et al., 1999 Lancet, vol. 354 (9174), “Condon 72 Polymorphism of p53 and Its Association with Cervical Cancer”, pp. 218-219.
Hakansson, et al., 1997 Am. J. Hum. Genet., vol. 60, No. 5, “Moderate Frequency of BRCA1 and BRCA2 Germ-Line Mutations in Scandinavian Familial Breast Cancer”, pp. 1068-1078.
Vaidya, et al. 1999 Lancet, vol. 354 (9180), “Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Gene Polymorphism Confers Susceptibility to Thyroid Associated Orbitopathy”, pp. 743-744.
Liao, et al., 1999 Angiology, vol. 50, No. 8, “A Missense Mutation of the Nitric Oxide Synthase (eNOS) Gene (Glu298Asp) in Five Patients with Coronary Artery Disease”, pp. 671-676.
Rust, et al., 1999 Nat. Genet, vol. 22, No. 4, “Tangier Disease id Caused by Mutations in the Gene Encoding ATP-Binding Cassette Transporter 1”, pp. 352-355.
Brooks-Wilson, 1999 Nat. Genet., vol. 22, No. 4, “Mutations in ABC1 Tangier Disease and Familial High-Density Lipoprotein Deficiency”, pp. 336-345.
Ligers, et al., 1999 Neuroimmunol., vol. 97(1-2), “The CTLA-4 Gene is Associated with Multiple Sclerosis”, pp. 182-190.
Shinar, et al., 1998 J. Mol. Neurosci., vol. 11, No. 3, “Analysis of Allelic Association Between D6S461 Marker and Multiple Sclerosis in Ashkenazi and Iraqi Jewish Patients”, pp. 265-269.
Schutte, et al, 1999 Am. J. Med. Genet., vol. 84, No. 2, “Microdeletions at Chromosome Bands 1q32-q41 As A Cause of Van der Woude Syndrome”, pp. 145-150.
Aita, et al., 1999 Am. J. Hum. Genet., vol. 64, No. 1, A Comprehensive Linkage Analysis of Chromosome 21q22 Supports Prior Evidence for A Putative Bipolar Affective Disorder Locus, pp. 210-217.
Campbell, et al., 1999 Mol. Psychiatry, vol. 4, No. 1, “Association Between A Marker in the UCP-2/UCP-3 Gene Cluster and Genetic Susceptibility to Anorexia Nervosa”, pp. 68-70.
Scacchi, et al., 1999 Neurosci. Lett., vol. 259, No. 1, “Plasma Levels of Apolipoprotein E and Genetic Markers In Elderly Patients With Alzheimer's Disease”, pp. 33-36.
Kruger, et al., 1999 Ann. Neurol., vol. 45, No. 5, “Increased Susceptibility to Sporadic Parkinson's Disease By A Certain Combined &agr;-Synuclein/Apolipoprotein E Genotype”, pp. 611-617.
First Genetic Trust Inc.
Kelly Edward J.
Lee Agnes S.
Ouellette Jonathan
Ropes & Gray LLP
LandOfFree
Genetic profiling and banking system and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic profiling and banking system and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic profiling and banking system and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3172764